Cargando…

COMMON NONCARDIOVASCULAR MULTIMORBIDITY PATTERNS AND OUTCOMES IN OLDER ADULTS WITH MAJOR CARDIOVASCULAR DISEASE

Non-cardiovascular multimorbidity often coexists in older adults with cardiovascular disease (CVD), but their clinical significance is uncertain. Using Medicare data, we examined common non-cardiovascular comorbidity patterns and their association with clinical outcomes in beneficiaries with congest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sison, Stephanie Denise, Lin, Joshua K, Najafzadeh, Mehdi, Patorno, Elisabetta, Bessette, Lily G, Zakoul, Heidi, Kim, Dae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9766724/ http://dx.doi.org/10.1093/geroni/igac059.2450

Ejemplares similares

Association of Selected Antipsychotic Agents With Major Adverse Cardiovascular Events and Noncardiovascular Mortality in Elderly Persons
por: Sahlberg, Marie, et al.
Publicado: (2015)

Pre-Existing Autoimmune Disease Increases the Risk of Cardiovascular and Noncardiovascular Events After Immunotherapy
por: Lee, Charlotte, et al.
Publicado: (2022)

Derivation of Patient-Defined Adverse Cardiovascular and Noncardiovascular Events Through a Modified Delphi Process
por: Sun, Louise Y., et al.
Publicado: (2021)

Neuropsychiatric consequences of coronary artery bypass grafting and noncardiovascular surgery
por: Reichenberg, Abraham, et al.
Publicado: (2007)

The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: Design and exposure accrual for an evaluation of empagliflozin in routine clinical care
por: Patorno, Elisabetta, et al.
Publicado: (2019)

Early noncardiovascular organ failure and mortality in the cardiac intensive care unit
por: Jentzer, Jacob C., et al.
Publicado: (2020)

Frailty as a Risk Factor for Cardiovascular Versus Noncardiovascular Mortality in Older Men: Results From the MrOS Sleep (Outcomes of Sleep Disorders in Older Men) Study
por: Adabag, Selcuk, et al.
Publicado: (2018)

Frailty, Home Time, and Health Care Costs in Older Adults With Atrial Fibrillation Receiving Oral Anticoagulants
por: Lin, Kueiyu Joshua, et al.
Publicado: (2023)

Association of Sodium-Glucose Cotransporter–2 Inhibitors With Fracture Risk in Older Adults With Type 2 Diabetes
por: Zhuo, Min, et al.
Publicado: (2021)

Competing Risks of Cardiovascular Versus Noncardiovascular Death During Long‐Term Follow‐Up After Acute Coronary Syndromes
por: Fanaroff, Alexander C., et al.
Publicado: (2017)

Association of Undifferentiated Dyspnea in Late Life With Cardiovascular and Noncardiovascular Dysfunction: A Cross-sectional Analysis From the ARIC Study
por: Ramalho, Sergio H. R., et al.
Publicado: (2019)

Prospective Monitoring of Newly Marketed Drugs in Frail Older Adults Using Real-World Databases
por: Kim, Dae, et al.
Publicado: (2021)

Genetically Predicted Differences in Systolic Blood Pressure and Risk of Cardiovascular and Noncardiovascular Diseases: A Mendelian Randomization Study in Chinese Adults
por: Clarke, Robert, et al.
Publicado: (2023)

Association Between Life's Simple 7 and Noncardiovascular Disease: The Multi‐Ethnic Study of Atherosclerosis
por: Ogunmoroti, Oluseye, et al.
Publicado: (2016)

High-Density Lipoprotein Subclasses and Noncardiovascular, Noncancer Chronic Inflammatory-Related Events Versus Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis
por: Duprez, Daniel A, et al.
Publicado: (2015)

UTILIZATION TRENDS OF GLUCOSE-LOWERING DRUGS FOR TYPE 2 DIABETES IN OLDER ADULTS WITH AND WITHOUT DEMENTIA
por: Gopalakrishnan, Chandrasekar, et al.
Publicado: (2022)

FRAILTY AND THE COMPARATIVE EFFECTIVENESS AND SAFETY OF SGLT2I AND SULFONYLUREA IN OLDER ADULTS WITH TYPE 2 DIABETES
por: Pawar, Ajinkya, et al.
Publicado: (2019)

FRAILTY AND THE EFFECTIVENESS AND SAFETY OF NEW GLUCOSE-LOWERING DRUGS IN OLDER ADULTS WITH TYPE 2 DIABETES
por: Kim, Dae H, et al.
Publicado: (2019)

Trends of ARNI and Other Heart Failure Medication Use in Older Adults
por: Lee, Yu-Chien, et al.
Publicado: (2021)

Monitoring Utilization Trends of Glucose-Lowering Drugs for Type 2 Diabetes in Older Adults by Frailty Status
por: Gopalakrishnan, Chandrasekar, et al.
Publicado: (2021)

FRAILTY AND THE COMPARATIVE EFFECTIVENESS AND SAFETY OF SGLT2I AND GLP1-RA IN OLDER ADULTS WITH TYPE 2 DIABETES
por: Patorno, Elisabetta, et al.
Publicado: (2019)

Long‐term incidence and risk of noncardiovascular and all‐cause mortality in apparently healthy cats and cats with preclinical hypertrophic cardiomyopathy
por: Fox, Philip R., et al.
Publicado: (2019)

Monitoring the Comparative Safety of SGLT2i vs GLP-1 RA in Older Adults With Type 2 Diabetes by Frailty Status
por: Kutz, Alexander, et al.
Publicado: (2021)

FRAILTY AND THE COMPARATIVE EFFECTIVENESS AND SAFETY OF SGLT2I AND DPP4I IN OLDER ADULTS WITH TYPE 2 DIABETES
por: Kim, Dae H, et al.
Publicado: (2019)

A CROSSWALK OF COMMONLY USED FRAILTY SCALES
por: Sison, Stephanie Denise, et al.
Publicado: (2022)

Polypharmacy Patterns in Multimorbid Older People with Cardiovascular Disease: Longitudinal Study
por: Villén, Noemí, et al.
Publicado: (2022)

Association of fine particulate matter exposure with acute noncardiovascular critical illnesses and in-hospital outcomes in patients receiving intensive cardiac care
por: Chen, Fei, et al.
Publicado: (2020)

Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics
por: Htoo, Phyo T., et al.
Publicado: (2022)

Bias Implications of Outcome Misclassification in Observational Studies Evaluating Association Between Treatments and All‐Cause or Cardiovascular Mortality Using Administrative Claims
por: Desai, Rishi J., et al.
Publicado: (2020)

Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis
por: D’Andrea, Elvira, et al.
Publicado: (2020)

Predicting Risk of Atherosclerotic Cardiovascular Disease Using Pooled Cohort Equations in Older Adults With Frailty, Multimorbidity, and Competing Risks
por: Nguyen, Quoc Dinh, et al.
Publicado: (2020)

Comparative Effectiveness and Safety of Oral Anticoagulants by Dementia Status in Older Patients With Atrial Fibrillation
por: Lin, Kueiyu Joshua, et al.
Publicado: (2023)

Outcomes of Common Major Surgical Procedures in Older Adults With and Without Dementia
por: Masutani, Rebecca, et al.
Publicado: (2020)

UTILIZATION TRENDS OF NEWLY APPROVED GLUCOSE-LOWERING DRUGS FOR TYPE 2 DIABETES
por: Dave, Chintan, et al.
Publicado: (2019)

Monitoring the Effectiveness and Safety of ARNI vs. Angiotensin Receptor Blocker by Frailty Status
por: Kim, Dae, et al.
Publicado: (2021)

Cardiovascular Safety, Long‐Term Noncardiovascular Safety, and Efficacy of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Systemic Review and Meta‐Analysis With Trial Sequential Analysis
por: Zhang, Xin‐Lin, et al.
Publicado: (2018)

2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards
por: Bozkurt, Biykem, et al.
Publicado: (2022)

Trends in the Use of Oral Anticoagulants for Adults With Venous Thromboembolism in the US, 2010-2020
por: Iyer, Geetha S., et al.
Publicado: (2023)

Goals of older hospitalized patients with multimorbidity
por: Tent, Sanne, et al.
Publicado: (2023)

Trajectories of functional decline in older adults with neuropsychiatric and cardiovascular multimorbidity: A Swedish cohort study
por: Vetrano, Davide L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mnb9an2tn7pp54ds653uv49dea